|
|
|
|
|
Article Summary |
 |
|
|
Doctors May
Screen Stool Samples for Cancer
(London, Reuters, 4/16/04)
Martin Winschwendter, Hannes M Mueller and associates from Austria's Medical
University Innsbruck, differentiated stools of colorectal cancer patients from
those of healthy subjects by examining the DNA in the stool. The SFRP2 genes
found in stool samples from cancer patients were likelier to have undergone the
chemical process of methylation than those found in stool from healthy
individuals. The researchers conclude that SFRP2 methylation is a sensitive
indicator of colorectal cancer.
|
|
|
|
Disclaimer: SmartTrac Computer Systems, Inc. does not warrant that the
information on this website is free of errors, inaccuracies or omissions. The
content of this website is presented for educational purposes only. It is
not intended as a substitute for the diagnosis, treatment and advice of a
qualified licensed professional.
© 2004-2010, SmartTrac Computer Systems, Inc.
All rights reserved.
The content of Health News Express is the intellectual property
of SmartTrac Computer Systems, Inc. Any use of the materials presented on
this website is expressly prohibited without prior written consent. |
|
|
